Medical research

Heroin vaccine blocks relapse in preclinical study

Scientists at The Scripps Research Institute (TSRI) have reported successful preclinical tests of a new vaccine against heroin. The vaccine targets heroin and its psychoactive breakdown products in the bloodstream, preventing ...

Medical research

New molecule stops drug cravings in mice, with fewer side effects

Duke University researchers have developed a synthetic molecule that selectively dampen the physiological rewards of cocaine in mice. It also may represent a new class of drugs that could be more specific with fewer side ...

Medications

Green synthesis of drug candidate for inflammatory bowel disease

Inflammatory bowel disease (IBD), characterized by a chronic inflammation of the digestive tract, is currently treated with steroids and antibody drugs. However, steroids have side effects, such as delayed healing, and antibody ...

Oncology & Cancer

RNA drugs one step closer to be being used in cancer treatment

In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas. However, it has been a challenge to develop techniques to deliver the RNA molecules ...

Alzheimer's disease & dementia

New drugs to find the right target to fight Alzheimer's disease

The future is looking good for drugs designed to combat Alzheimer's disease. EPFL scientists have unveiled how two classes of drug compounds currently in clinical trials work to fight the disease. Their research suggests ...

Cardiology

Dental plaque bacteria may trigger blood clots

Oral bacteria that escape into the bloodstream are able to cause blood clots and trigger life-threatening endocarditis. Further research could lead to new drugs to tackle infective heart disease, say scientists presenting ...

page 8 from 28